Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins.
暂无分享,去创建一个
[1] D. Kohn,et al. Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. , 1999, Blood.
[2] D. Richman,et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. , 1999, Science.
[3] V. Sasseville,et al. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages , 1999, Nature Medicine.
[4] Anthony S. Fauci,et al. Both Memory and CD45RA+/CD62L+ Naive CD4+ T Cells Are Infected in Human Immunodeficiency Virus Type 1-Infected Individuals , 1999, Journal of Virology.
[5] D. Littman,et al. Cytokine Signals Are Sufficient for HIV-1 Infection of Resting Human T Lymphocytes , 1999, The Journal of experimental medicine.
[6] M Geyer,et al. Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. , 1999, Molecular cell.
[7] A. McMichael,et al. Induction of Fas Ligand Expression by HIV Involves the Interaction of Nef with the T Cell Receptor ζ Chain , 1999, The Journal of experimental medicine.
[8] D. Trono,et al. Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery , 1998, Journal of Virology.
[9] M. Malim,et al. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. , 1998, Science.
[10] B. Cullen. HIV-1 Auxiliary Proteins: Making Connections in a Dying Cell , 1998, Cell.
[11] B. Walker,et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.
[12] M A Nowak,et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[13] D. Peterson,et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors , 1997, Nature Genetics.
[14] F. Gage,et al. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] Luigi Naldini,et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo , 1997, Nature Biotechnology.
[16] P. Walker,et al. TCR analysis reveals significant repertoire selection during in vitro lymphocyte culture. , 1997, International immunology.
[17] J. Belmont,et al. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene. , 1997, Human gene therapy.
[18] S. Karlsson,et al. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[19] C. Cheng‐Mayer,et al. Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques , 1996, Current Biology.
[20] F. Gage,et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[21] C. Cheng‐Mayer,et al. HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis. , 1996, Virology.
[22] M. Malim,et al. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes , 1996, Journal of virology.
[23] M. Tremblay,et al. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. , 1996, Virology.
[24] F. Gage,et al. In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.
[25] M. Stevenson. Pathway to understanding AIDS , 1996, Nature Structural Biology.
[26] F. Lemonnier,et al. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein , 1996, Nature Medicine.
[27] S. Rosenberg,et al. T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years , 1995, Science.
[28] Evelina Mazzolari,et al. Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA− Immunodeficient Patients , 1995, Science.
[29] J. Hildreth,et al. HIV acquires functional adhesion receptors from host cells. , 1995, AIDS research and human retroviruses.
[30] D. Trono,et al. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis , 1995, Journal of virology.
[31] S. Zolla-Pazner,et al. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1 , 1995, The Journal of experimental medicine.
[32] D. Trono,et al. HIV accessory proteins: Leading roles for the supporting cast , 1995, Cell.
[33] C. Castilletti,et al. HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells. , 1995, AIDS research and human retroviruses.
[34] D. Richman,et al. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro , 1995, Journal of virology.
[35] F. Rey,et al. Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps , 1995, Journal of virology.
[36] D. Baltimore,et al. Proline‐rich (PxxP) motifs in HIV‐1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down‐regulation of CD4. , 1995, The EMBO journal.
[37] R. Seder. Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, The Journal of allergy and clinical immunology.
[38] C. Cheng‐Mayer,et al. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. , 1994, Immunity.
[39] D. Trono,et al. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Emerman,et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[41] C. Bordignon,et al. Peripheral Blood Lymphocytes as Target Cells of Retroviral Vector-Mediated Gene Transfer , 1994 .
[42] D. Trono,et al. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells , 1993, Journal of virology.
[43] J. Sodroski,et al. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes , 1992, Journal of virology.
[44] M. Stevenson,et al. HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.
[45] Jerome A. Zack,et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.
[46] A. Fisher,et al. The sor gene of HIV-1 is required for efficient virus transmission in vitro. , 1987, Science.
[47] C. Cheng‐Mayer,et al. Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[48] R. Cheynier,et al. Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. , 1986, Science.
[49] S. Rosenberg,et al. Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen. , 1995, Blood.
[50] P. Sova,et al. The human immunodeficiency virus type 1 vif gene: the road from an accessory to an essential role in human immunodeficiency virus type 1 replication. , 1995, Current topics in microbiology and immunology.
[51] W. Telford,et al. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. , 1992, Cytometry.
[52] J. Hoxie,et al. Nonrandom association of cellular antigens with HTLV-III virions. , 1987, Human immunology.